Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.43 NOK Market Closed
Market Cap: 565m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Hofseth Biocare ASA
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hofseth Biocare ASA
Capital Expenditures Peer Comparison

Comparables:
B
BGBIO
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Hofseth Biocare ASA
OSE:HBC
Capital Expenditures
-kr9.3m
CAGR 3-Years
45%
CAGR 5-Years
-113%
CAGR 10-Years
5%
B
Bergenbio ASA
OSE:BGBIO
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Capital Expenditures
-kr49k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Capital Expenditures
-kr20.4m
CAGR 3-Years
-71%
CAGR 5-Years
-57%
CAGR 10-Years
-29%
N
Nykode Therapeutics ASA
OSE:NYKD
Capital Expenditures
-$1.1m
CAGR 3-Years
-124%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hofseth Biocare ASA's Capital Expenditures?
Capital Expenditures
-9.3m NOK

Based on the financial report for Jun 30, 2024, Hofseth Biocare ASA's Capital Expenditures amounts to -9.3m NOK.

What is Hofseth Biocare ASA's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
5%

Over the last year, the Capital Expenditures growth was 43%. The average annual Capital Expenditures growth rates for Hofseth Biocare ASA have been 45% over the past three years , -113% over the past five years , and 5% over the past ten years .

Back to Top